Multicenter retrospective study to evaluate the impact of trabectedin plus pegylated liposomal doxorubicin on the subsequent treatment in women with recurrent, platinum-sensitive ovarian cancer

Overview of attention for article published in Anti-Cancer Drugs, July 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

So far, Altmetric has seen 6 X posts from 5 X users, with an upper bound of 16,352 followers.

#PublicaSalutIb Impacte de la trabectedina més doxorubicina liposomal pegilada en el tractament del càncer d'ovari recurrent sensible al platí https://t.co/PB9vV96ZYW @SonLlatzer https://t.co/OZz2o2VzK5 https://t.co/r1Ql72Qnvg

#PublicaSalutIB Impacto de la trabectedina más doxorubicina liposomal pegilada en el tratamiento del cáncer de ovario recurrente sensible al platino https://t.co/WdpwG5PM0o @SonLlatzer https://t.co/UH71NvntT1 https://t.co/EwPd9kDQrB

#PublicaSalutIb Impacte de la trabectedina més doxorubicina liposomal pegilada en el tractament del càncer d'ovari recurrent sensible al platí https://t.co/MBme56YK1J @SonLlatzer https://t.co/UH71NvntT1 https://t.co/EfyMbUPyET

RT @Saludteca: Multicenter retrospective study to evaluate the impact of trabectedin plus pegylated liposomal doxorubicin on the subsequen…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.